ASAH1 and early-onset autosomal dominant Alzheimer disease: In a mouse model of Alzheimer’s disease, the administration of 2′,5′-Dideoxyadenosine, an AC inhibitor, led to a significant increase in NSC and NCP populations, which correlated with improvements in age-related cognitive and behavioral deficits.